【机构调研记录】睿远基金调研莱特光电、福瑞股份等3只个股（附名单）

Group 1: 莱特光电 (Lite-On Optoelectronics) - In the first half of 2025, Lite-On achieved revenue of 292 million yuan, a year-on-year increase of 18.84%, and a net profit of 126 million yuan, up 36.74% year-on-year, driven by rising demand in the OLED market and cost reduction efforts [1] - The company’s OLED terminal material products cover red, green, and blue emitting layer materials and core functional layer materials, with new products gradually entering mass production [1] - The construction of the 8.6-generation line is accelerating, which is expected to significantly boost the demand for OLED organic light-emitting materials, providing a broad development space for the company's material business [1] Group 2: 福瑞股份 (Furui Co., Ltd.) - Furui announced that Novo Nordisk approved the new MASH indication application for semaglutide, marking a significant development phase for the industry, and the company is collaborating with Novo Nordisk to advance early diagnosis and treatment of MASH [2] - The company reported sufficient orders despite not yet receiving feedback from distributors and hospitals regarding the newly approved MASH indication [2] - The performance of the traditional Chinese medicine segment has improved mainly due to e-commerce growth, driven by increased national focus on obesity and fatty liver disease [2] Group 3: 中矿资源 (China Mineral Resources) - In the first half of 2025, China Mineral Resources reported revenue of 3.27 billion yuan, a year-on-year increase of 34.89%, but net profit decreased by 81.16% to 89 million yuan [3] - The rare light metal segment (cesium and rubidium) performed well, with revenue of 708 million yuan, up 50.43% year-on-year, and gross profit of 511 million yuan, also up 50.15% [3] - The company has initiated a project to produce 30,000 tons of high-purity lithium salt annually and has acquired stakes in copper mining projects in Zambia and Namibia to enhance its resource integration capabilities [3] Group 4: 睿远基金 (Ruiyuan Fund) - Ruiyuan Fund, established in 2018, has an asset management scale of 46.215 billion yuan, ranking 87th among 210 in total public funds [4] - The fund's best-performing product over the past year is Ruiyuan Growth Value Mixed A, with a latest net value of 1.66, reflecting a growth of 63.23% in the past year [4]